Publication date: Oct 03, 2024
Treatment modifications and contact restrictions were common during the COVID-19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic-related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65. 5 years, ≤5 years post-diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden-WcFCrttemberg Cancer Registry, Germany. Sociodemographic information, pandemic-related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self-administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22% of participants reported oncological care modifications due to COVID-19, mostly in follow-up care and rehabilitation. Modifications of active cancer treatment were reported by 5. 8%. Among those, 50. 5% had subclinical anxiety and 55. 4% subclinical depression (vs. 37. 4% and 45. 4%, respectively, for unchanged active treatment). Age
| Concepts | Keywords |
|---|---|
| 5years | cancer registry |
| Cancer | mental health |
| Covid | SARS‐CoV‐2 |
| Germany | social contact |
| Sociodemographic | treatment modifications |
| well‐being |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Anxiety |
| disease | MESH | depression |
| disease | MESH | cancer |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | colorectal cancer |
| pathway | KEGG | Colorectal cancer |
| disease | MESH | leukemia |
| disease | MESH | lymphoma |